S16 Ep38: Live Tumor Board: Precision Pathways Transforming Patient Care in Advanced NSCLC
Highlights from the PER® CME activity "Live Tumor Board: Precision Pathways Transforming Patient Care in Advanced NSCLC" — this podcast is not certified for credit. To participate in the full accredited activity and earn CME credit, use the link below.
In this podcast, experts Narjust Florez, MD, FASCO; David Carbone, MD, PhD; and Edward Garon, MD, MS; discuss the use of KRAS-, NRG1-, MET-, and ROS1-targeting agents to transform patient care in advanced non–small cell lung cancer (NSCLC).
Earn CME credit by completing the full accredited activity (available through March 27, 2027)…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.